|Weight:||0.5 mg/5 ml|
|Therapeutic Class:||Antidote preparations, Benzodiazepine antagonist|
|Manufacturer:||Roche Bangladesh Limited|
|Last Updated:||2020-11-20 18:15:00|
Anexate IV Injection contains Flumazenil. Anexate uses:
Reversal of benzodiazepine-induced sedation, Benzodiazepine overdose
Anexate IV Injection contains Flumazenil 0.5 mg/5 ml. Anexate doses:
Intravenous- Reversal of benzodiazepine-induced sedation
Dizziness, pain at inj site, increased sweating, headache, abnormal or blurred vision, nausea, vomiting, palpitations, anxiety, fear, transient HTN, flushing, agitation, chills, sensory disturbances.
Flumazenil, an imidazobenzodiazepine derivative, competitively inhibits the activity at the benzodiazepine recognition site on the GABA/benzodiazepine receptor complex.
Patient with head injury, alcoholism and other drug dependencies, history of panic disorder. Not intended to treat benzodiazepine dependence or withdrawal syndrome. Should only be used until effects of neuromuscular blockade have been fully reversed. Hepatic impairment. Pregnancy and lactation.
Antagonises central effects of benzodiazepines and non-benzodiazepine agonists (e.g. zopiclone, triazolopyridazine) by competitive interaction at the receptor.
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.
Patient receiving benzodiazepines to control potentially life-threatening conditions (e.g. status epilepticus, raised intracranial pressure). Severe intoxication w/ tricyclic and related antidepressants.
Store between 20-25°C.
Anexate IV Injection price in Bangladesh 2.80